International Stem Cell holders elect directors

International Stem Cell Corporation reported voting results from its Annual Meeting of Stockholders held on June 11, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

International Stem Cell Corporation reported voting results from its Annual Meeting of Stockholders held on June 11, 2026. Stockholders voted on the election of directors described in the proxy dated April 24, 2026.

All named director candidates, including Andrey Semechkin, Russell Kern, Donald A. Wright, and Paul V. Maier, were elected. Support was strong, with 2,457,143 votes "for" Semechkin and Kern, and over 9.28 million votes "for" Wright and Maier against relatively small withheld votes. The company reported no broker non-votes in this election.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Votes for Andrey Semechkin: 2,457,143 votes Votes for Russell Kern: 2,457,143 votes Votes for Donald A. Wright: 9,288,444 votes for; 30,590 withheld +2 more

5 metrics

Votes for Andrey Semechkin 2,457,143 votes Director election at Annual Meeting on June 11, 2026

Votes for Russell Kern 2,457,143 votes Director election at Annual Meeting on June 11, 2026

Votes for Donald A. Wright 9,288,444 votes for; 30,590 withheld Director election at Annual Meeting on June 11, 2026

Votes for Paul V. Maier 9,288,500 votes for; 30,534 withheld Director election at Annual Meeting on June 11, 2026

Broker non-votes none Director election voting results

Key Terms

Annual Meeting of Stockholders, definitive proxy statement, Broker Non-Votes, withheld

4 terms

Annual Meeting of Stockholders regulatory

"held its Annual Meeting of Stockholders on June 11, 2026"

definitive proxy statement regulatory

"described in more detail in the Company’s definitive proxy statement dated April 24, 2026"

A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.

Broker Non-Votes regulatory

"Broker Non-Votes: none"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

withheld financial

"Donald A. Wright | 9,288,444 | | 30,590 |"

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/12/2026 - 07:57 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 11, 2026

INTERNATIONAL STEM CELL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

000-51891

20-4494098

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification Number)

9745 Businesspark Ave, San Diego, California 92131

(Address of principal executive offices, including zip code)

(760) 940-6383

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CAR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.07 Submission of Matters to a Vote of Security Holders

International Stem Cell Corporation (the “Company”) held its Annual Meeting of Stockholders on June 11, 2026. The stockholders considered one proposal, which is described in more detail in the Company’s definitive proxy statement dated April 24, 2026.

Proposal 1:

Election of four directors to hold office until the 2027 Annual Meeting:

Directors elected by holders of Series D Preferred Stock:

	FOR	WITHHELD
Andrey Semechkin	2,457,143	0
Russell Kern	2,457,143	0

Directors elected by holders of all shares of stock (including shares of preferred stock voting on an as-converted basis):

	FOR	WITHHELD
Donald A. Wright	9,288,444	30,590
Paul V. Maier	9,288,500	30,534

Broker Non-Votes: none

All of the foregoing candidates were elected.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	INTERNATIONAL STEM CELL CORPORATION


Date: June 12, 2026	By:	/s/ Russell Kern
		Russell Kern
		Executive Vice President, Chief Scientific Officer and Principal Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

International Stem Cell holders elect directors

Rhea-AI Filing Summary

8-K Event Classification

Key Figures

Key Terms

Filing Exhibits & Attachments

Other Documents

Keep reading

More on ISCO

Trending in the feed